复发性和转移性头颈癌的免疫治疗与生物标志物检测：美国临床肿瘤学会指南问答 - Suppr

Suppr

超能文献

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A.

作者信息

Yilmaz Emrullah, Ismaila Nofisat, Dabney Raetasha, Saba Nabil F, Mell Loren K

机构信息

Cleveland Clinic, Cleveland, OH.

American Society of Clinical Oncology (ASCO), Alexandria, VA.

出版信息

JCO Oncol Pract. 2023 Apr;19(4):194-196. doi: 10.1200/OP.22.00802. Epub 2023 Jan 26.

DOI:10.1200/OP.22.00802

PMID:36701647

Abstract

摘要

相似文献

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A.复发性和转移性头颈癌的免疫治疗与生物标志物检测：美国临床肿瘤学会指南问答

JCO Oncol Pract. 2023 Apr;19(4):194-196. doi: 10.1200/OP.22.00802. Epub 2023 Jan 26.

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.免疫治疗和生物标志物检测在复发性和转移性头颈部癌症中的应用：ASCO 指南。

J Clin Oncol. 2023 Feb 10;41(5):1132-1146. doi: 10.1200/JCO.22.02328. Epub 2022 Dec 15.

[Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the ASCO Meeting 2016].[头颈部鳞状细胞癌复发和远处转移的治疗：2016年美国临床肿瘤学会会议要点]

HNO. 2016 Oct;64(10):723-30. doi: 10.1007/s00106-016-0235-6.

Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.头颈部鳞状细胞癌新辅助免疫治疗的理由。

Oral Oncol. 2017 Oct;73:65-69. doi: 10.1016/j.oraloncology.2017.08.008. Epub 2017 Aug 17.

[Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the 2018 ASCO meeting].[头颈部鳞状细胞癌复发和远处转移的治疗：2018年美国临床肿瘤学会会议要点]

HNO. 2018 Dec;66(12):907-912. doi: 10.1007/s00106-018-0580-8.

[Trials in head and neck cancer - Highlights of the ASCO Annual Meeting 2021].[头颈部癌试验——2021年美国临床肿瘤学会年会亮点]

Laryngorhinootologie. 2021 Oct;100(10):774-780. doi: 10.1055/a-1578-0281. Epub 2021 Sep 1.

[Immunotherapy for head and neck squamous cell carcinoma].[头颈部鳞状细胞癌的免疫疗法]

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Feb 7;52(2):143-147. doi: 10.3760/cma.j.issn.1673-0860.2017.02.019.

[Immunotherapy highlights of the ASCO annual meeting 2018 for head and neck cancers].2018年美国临床肿瘤学会年会头颈部癌症免疫治疗亮点

HNO. 2018 Dec;66(12):880-887. doi: 10.1007/s00106-018-0586-2.

[Therapy of recurrent and metastatic squamous cell carcinoma of the head and neck : highlights of the ASCO Meeting 2013].[复发性及转移性头颈部鳞状细胞癌的治疗：2013年美国临床肿瘤学会会议要点]

HNO. 2013 Nov;61(11):911-3. doi: 10.1007/s00106-013-2768-2.

Checkpoint immunotherapy in head and neck cancers.头颈部癌症中的免疫检查点疗法。

Cancer Metastasis Rev. 2017 Sep;36(3):475-489. doi: 10.1007/s10555-017-9694-9.

引用本文的文献

Predictive value of CPS combined with inflammatory markers for pathological remission of locally advanced head and neck squamous cell carcinoma after adjuvant immunochemotherapy.CPS联合炎症标志物对局部晚期头颈部鳞状细胞癌辅助免疫化疗后病理缓解的预测价值

Front Mol Biosci. 2025 May 1;12:1593742. doi: 10.3389/fmolb.2025.1593742. eCollection 2025.

Multi-omics and machine learning-driven CD8 T cell heterogeneity score for head and neck squamous cell carcinoma.多组学和机器学习驱动的头颈部鳞状细胞癌CD8 T细胞异质性评分

Mol Ther Nucleic Acids. 2024 Dec 5;36(1):102413. doi: 10.1016/j.omtn.2024.102413. eCollection 2025 Mar 11.

From standard therapies to monoclonal antibodies and immune checkpoint inhibitors - an update for reconstructive surgeons on common oncological cases.从标准疗法到单克隆抗体和免疫检查点抑制剂 - 为重建外科医生提供常见肿瘤病例的最新信息。

Front Immunol. 2024 Apr 23;15:1276306. doi: 10.3389/fimmu.2024.1276306. eCollection 2024.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验